Enhancement of cardiomyocyte differentiation from human embryonic stem cells

Science China Life Sciences

Volumn 53, Issue 5, 2010, Pages 581-589

  Wang, Yan Xia ^a   Chen, Gui An ^a   Song, Tian Ran ^a   Mao, Gen Hong ^a   Bai, Hai Yan ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

5 aza dC; Ascorbic acid; Cardiomyocyte differentiation; Human embryonic stem cells; Serum

Indexed keywords

ASCORBIC ACID; AZACITIDINE; BIOLOGICAL MARKER; DIMETHYL SULFOXIDE; CULTURE MEDIUM;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL LINE; COMPARATIVE STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; METHODOLOGY; DRUG EFFECTS; PHARMACOLOGY; PROCEDURES;

ADULT; ASCORBIC ACID; AZACITIDINE; BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CULTURE MEDIA; DIMETHYL SULFOXIDE; EMBRYONIC STEM CELLS; HUMANS; MYOCYTES, CARDIAC;

EID: 77953796480     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-0111-7     Document Type: Article

References (41)

1. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol, 2004, 22: 1282-1289.
2. Dai W, Field L J, Rubart M, et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol, 2007, 43: 504-516.
3. Kehat I, Kenyagin-Karsenti D, Snir M, et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest, 2001, 108: 407-414.
4. Xu C, Police S, Rao N, et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res, 2002, 91: 501-508.
5. Pal R, Khanna A. Similar pattern in cardiac differentiation of human embryonic stem cell lines, BG01V and ReliCellhES1, under low serum concentration supplemented with bone morphogenetic protein-2. Differentiation, 2007, 75: 112-122.
6. Mummol-Lery C, Ward-van Oostwaard D, Doevendans P, et al. Differentiation of human embryonic stem cells to cardiomyocytes. Circulation, 2003, 107: 2638-2639.
7. Passier R, Oostwaard D W, Snapper J, et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells, 2005, 23: 772-780.
8. Moore J C, van Laake L W, Braam S R, et al. Human embryonic stem cells: genetic manipulation on the way to cardiac cell therapies. Reprod Toxicol, 2005, 20: 377-391.
9. McDevitt T C, Laflammol/Le M A, Murry C E. Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol, 2005, 39: 865-873.
10. Burridge P W, Anderson D, Priddle H, et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells, 2007, 25: 929-938.
11. Monzen K, Shiojima I, Hiroi Y, et al. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2. 5 and GATA-4. Mol Cell Biol, 1999, 19: 7096-7105.
12. Wobus A M, Kaomei G, Shan J, et al. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol, 1997, 29: 1525-1539.
13. Hiroi Y, Kudoh S, Monzen K, et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet, 2001, 28: 276-280.
14. Kawai T, Takahashi T, Esaki M, et al. Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ J, 2004, 68: 691-702.
15. Yoon B S, Yoo S J, Lee J E, et al. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation, 2006, 74: 149-159.
16. Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs, 2001, 25: 187-193.
17. Lough J, Barron M, Brogley M, et al. Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm. Dev Biol, 1996, 178: 198-202.
18. Yuasa S, Itabashi Y, Koshimizu U, et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol, 2005, 23: 607-611.
19. Takahashi T, Lord B, Schulze P C, et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation, 2003, 107: 1912-1916.
20. Hong-mei P, Gui-an C. Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines. Hum Reprod, 2006, 21: 217-222.
21. Maltsev V A, Rohwedel J, Hescheler J, et al. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev, 1993, 44: 41-50.
22. Hosseinkhani M, Hasegawa K, Ono K, et al. Trichostatin A induces myocardial differentiation of monkey ES cells. Biochem Biophys Res Commol/Lun, 2007, 356: 386-391.
23. Abdelalim E M, Takada T, Toyoda F, et al. In vitro expression of natriuretic peptides in cardiomyocytes differentiated from monkey embryonic stem cells. Biochem Biophys Res Commol/Lun, 2006, 340: 689-695.
24. Xue T, Cho H C, Akar F G, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes insights into the development of cell-based pacemakers. Circulation, 2005, 111: 11-20.
25. Dolnikov K, Shilkrut M, Zeevi-Levin N, et al. Functional properties of human embryonic stem cell-derived cardiomyocytes. Ann NY Acad Sci, 2005, 1047: 66-75.
26. Reppel M, Boettinger C, Hescheler J. Beta-adrenergic and muscarinic modulation of human embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem, 2004, 14: 187-196.
27. Xiong C, Tang D Q, Xie C Q, et al. Genetic engineering of human embryonic stem cells with lentiviral vectors. Stem Cells Dev, 2005, 14: 367-377.
28. Kehat I, Gepstein A, Spira A, et al. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes a novel in vitro model for the study of conduction. Circ Res, 2002, 91: 659-661.
29. He J Q, Ma Y, Lee Y, et al. Human embryonic stem cells develop into multiple types of cardiac myocytes action potential characterization. Circ Res, 2003, 93: 32-39.
30. Satin J, Kehat I, Caspi O, et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol, 2004, 559: 479-496.
31. Segev H, Kenyagin-Karsenti D, Fishman B, et al. Molecular analysis of cardiomyocytes derived from human embryonic stem cells. Dev Growth Differ, 2005, 47: 295-306.
32. Norstrom A, Akesson K, Hardarson T, et al. Molecular and pharmacological properties of human embryonic stem cell-derived cardiomyocytes. Exp Biol Med, 2006, 231: 1753-1762.
33. St John J C, Ramalho-Santos J, Gray H L, et al. The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. Cloning Stem Cells, 2005, 7: 141-153.
34. Xu C, He J Q, Kamp T J, et al. Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum. Stem Cells Dev, 2006, 15: 931-941.
35. Czyz J, Wobus A M. Embryonic stem cell differentiation: the role of extracellular factors. Differentiation, 2001, 68: 167-174.
36. Baharvand H, Azarnia M, Parivar K, et al. The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. J Mol Cell Cardiol, 2005, 38: 495-503.
37. Cui L, Johkura K, Takei S, et al. Structural differentiation, proliferation, and association of human embryonic stem cell-derived cardiomyocytes in vitro and in their extracardiac tissues. J Struct Biol, 2007, 158: 307-317.
38. O'Brien P J, Smith D E C, Knechtel T J, et al. Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim, 2006, 40: 153-171.
39. Baba S, Heike T, Yoshimoto M, et al. Flk1+ cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model. Cardiovasc Res, 2007, 76: 119-131.
40. Welikson R E, Kaestner S, Evans A M, et al. Embryonic cardiomyocyte expression of endothelial genes. Dev Dyn, 2007, 236: 2512-2522.
41. Snir M, Kehat I, Gepstein A, et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol, 2003, 285: 2355-2363.